TINA HALE: Open Payments
NPI 1922355239 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 36 payments from 16 companies in 2025. Trend: 2023 $1,330 · 2024 $1,707 · 2025 $1,113
Food & beverage: $913Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $306 |
| Astellas Pharma US Inc | 5 | $204 |
| Endo USA, Inc. | 5 | $109 |
| ABBVIE INC. | 5 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $89 |
| Dendreon Pharmaceuticals LLC | 2 | $65 |
| Ferring Pharmaceuticals Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Tempus AI, Inc | 1 | $27 |
| Teleflex LLC | 1 | $24 |
Products named: ERLEADA, RYBREVANT, XIAFLEX, BOTOX, Xtandi, Nubeqa, PROVENGE, ADSTILADRIN.
Industry payments across GA — which companies pay providers there.
